Arbutus Biopharma (NASDAQ:ABUS) shares jumped 24% after hours Tuesday, while Roivant Sciences (NASDAQ:ROIV) rose 6.5% and ...
Nexcom APPC 160/210 C21 panel PCs Unleashing the Ingenuity of SD Edge Computing with AIoT and AI Computing products New ...
A Brisbane-based biotechnology company behind a needle-free vaccine patch has warned it could take its technology offshore after securing a multimillion-dollar funding boost from European authorities, ...
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving COVID shots. There's a catch: The mRNA technology ...
New bibliometric tool combs through scientific literature, patents, and grants to forecast future impact, but experts ...
Since being sworn in as Health and Human Services (HHS) secretary, Robert F. Kennedy Jr has repeatedly tried to undermine public trust in vaccines. His agency recently took steps to slow down the ...
The recent downturn follows Moderna’s announcement that its melanoma vaccine, mRNA-4157, showed promising results in a Phase 2b study, reducing the risk of recurrence or death by 49% when combined ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...
Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results